Autori: Shaunik Alka
| Naslov | Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial (Article) |
| Autori | McCrimmon Rory J Al Sifri Saud Emral Rifat Mohan Viswanathan Sauque-Reyna Leobardo Trescoli Carlos Lalic Nebojsa M Alvarez Agustina Demil Nacima Coudert Mathieu Shaunik Alka Bonnemaire Mireille Rosenstock Julio |
| Info | DIABETES OBESITY & METABOLISM, (2021), vol. 23 br. 6, str. 1221-1231 |
| Projekat | Sanofi, Paris, France |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
